SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following news of a major AI partnership with OpenAI, including a chip supply deal and potential equity stake. Community discussions highlight the deal's impact on AMD's competition with Nvidia and its validation of AMD's AI strategy. Traders are watching for continued momentum and potential price targets, while also considering the broader implications for the AI sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to reports of potential U.S. government investment in its Greenland rare earth mine, sparking excitement among investors who see it as a strategic national asset. The community is actively discussing the potential for significant gains, comparing it to similar government-backed initiatives in the sector. High trading volume and a low float are contributing to the stock's volatility as traders speculate on upcoming milestones and potential for a short squeeze.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

SLDP is trending as investors discuss the potential for a short squeeze, with some citing high short interest and warrant availability as catalysts. Community members are also highlighting the company's partnerships with BMW and SK On, and the progress toward commercialization of solid-state battery technology. Some are drawing attention to the potential applications of solid-state batteries in AI infrastructure and beyond EVs, indicating a broadening scope of interest.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its vision of culture, peace, and digital freedom, emphasizing the project's focus on purpose and long-term growth rather than fleeting hype. Community members highlight the coin's unique appeal, describing it as more than just a token, but a movement towards a more connected and empowered digital future. Discussions also include references to community spaces and the project's website, suggesting active engagement and development within the Weedcoin ecosystem.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as the critical minerals sector gains momentum, with community members discussing the potential for a short squeeze and speculating on government support following similar developments with other companies in the space. The stock is nearing its 52-week high, and investors are eyeing key resistance levels with anticipation of NOAA approval news acting as a major catalyst. Community conversations also highlight discussions around chart patterns, potential for further upside, and the long-term vision for deep-sea mining.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending following FDA breakthrough therapy designation for its tralesinidase alfa therapy targeting Sanfilippo Syndrome Type B, a rare genetic disease. Community members are discussing the potential for a significant squeeze given the small float and are speculating about potential price targets, some even suggesting triple-digit gains. The designation is seen as a major catalyst, with some drawing comparisons to other biotech stocks that have experienced similar surges after positive FDA news.

HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. It operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. The firm owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. Its project includes Iceland Cryptocurrency Mining. HIVE Digital Technologies was founded on June 24, 1987 and is headquartered in San Antonio, TX.

HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd

HIVE Digital Technologies is trending as community members discuss the stock's potential, fueled by news of increased Bitcoin production and a new data center acquisition. Bullish sentiment is building, with many believing HIVE is undervalued compared to its peers in the crypto mining and AI infrastructure sectors. Discussions include potential price targets and the company's growth prospects in high-performance computing.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as investors discuss its potential in automation, energy, and AI sectors through battery recycling. Community members are focused on the company's potential for growth and are eagerly anticipating news regarding upcoming targets and announcements. Bullish sentiment is fueled by discussions of domestic lithium supply development and the possibility of partnerships or buyouts.

Streamex Corp. operates as a Real-World Asset (RWA) tokenization. It engages in the provision of blockchain technology to tokenize physical commodities such as gold and create related financial products. The company was founded by Kenneth L. Londoner, Karl Henry McPhie, and Morgan Lekstrom on February 24, 2009 and is headquartered in Winter Park, FL.

Streamex Corp.

Streamex (STEX) is trending due to its recent announcement of a pre-sale for GLDY, a gold-backed stablecoin, generating excitement around the tokenization of gold and a potential short squeeze. The community is actively discussing the company's strong management team and the potential for significant gains as it positions itself in the gold-backed digital asset space. Bullish sentiment is fueled by unusual options activity and speculation around potential investments.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

GSR III Acquisition Corp. - Ordinary Shares- Class A

GSR III Acquisition Corp. Ordinary Shares

GSRT is trending due to its upcoming merger with Terra Innovatum, a micro-modular nuclear reactor company, and anticipation of the ticker changing to NKLR. The community is discussing the potential for growth in the nuclear sector, especially with increased demand for AI data centers and crypto mining, while drawing comparisons to other companies like $OKLO. Some traders believe the stock is undervalued, presenting a compelling investment opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CLPT Expands Into Robotic System Supporting Cell and Gene Therapies

ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.

GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent

GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.

Masimo Completes Divestment of Consumer Audio Business to HARMAN

MASI completes sale of Sound United to HARMAN, sharpening focus on core healthcare, boosting margins, and funding buybacks.

Here's Why You Should Add Inogen Stock to Your Portfolio Now

Expanding product portfolio and high prospects for POC raise optimism for INGN stock.

Are Medical Stocks Lagging  AxoGen (AXGN) This Year?

Here is how AxoGen (AXGN) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?

The mean of analysts' price targets for AxoGen (AXGN) points to a 53.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Axogen, Inc. (AXGN) announced on Monday that the U.S. Food and Drug Administration (FDA) has postponed the date by which it would decide on the company’s application requesting approval for Avance Nerve Graft.Shares of the company tumbled 15% in Monday’s pre-market session after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.axogeninc.com/press-releases/detail/1007/axogen-provides-update-on-fda-review-timeline-for-avance">announced</a> that the agency pushed the date of the decision by three months to Dec. 5, 2025. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves.An "off-the-shelf" processed human nerve allograft is a biologically active implant made from donated human nerve tissue that is surgically treated to remove cellular and non-cellular debris, preserving the native nerve's structural integrity. Unlike traditional autografts, allografts are "off-the-shelf," meaning they are immediately available for surgical use.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AXGN">AXGN stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘low’ levels.The company said that it received communication from the FDA on August 22, indicating that the information it submitted in response to an FDA information request was deemed a major amendment to its initial application filed in September 2024 and accepted by the agency in November. The company submitted fresh data, including substantial new manufacturing and facility data, in response to the request.FDA subsequently extended the date for making its decision, allowing for additional time to review the submission. The FDA also told the company that it now expects to provide feedback on product labelling in November.CEO Michael Dale said that the company looks forward to continuing engagement with the FDA to get Avance approved.AXGN stock is down by 1% this year but up by about 28% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-slides-to-july-levels-ethereum-retreats-from-weekend-highs/chssNkNRd1i">Bitcoin Slides To July Levels, Ethereum Retreats From Weekend Highs – $840M Liquidated In Crypto Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Is Axogen Stock Down 15% In Pre-Market Today?

Axogen stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.

Equity

The stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.


Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 76.4% in AxoGen (AXGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of +0.68% and +3.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Axogen Inc.

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

AXGN
Axogen Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AXGN News

AXGN Axogen Inc.